FDA Drug Shortages — Page 4

1,695 drug shortages total

Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,695 drug shortages from official FDA sources, updated on an ongoing basis.

FDA Drug Shortages (page 4 of 34)

Drug shortages	Details
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Cisatracurium Besylate Injection	To Be Discontinued — Hospira, Inc., a Pfizer Company
Alteplase Injection	To Be Discontinued — Genentech, Inc
Cromolyn Sodium Concentrate	Current — Ailex Pharmaceuticals
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Sulconazole Nitrate Solution	To Be Discontinued — Journey Medical Corporation
Quinapril/Hydrochlorothiazide Tablet	Current — Pfizer Inc.
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Sodium Acetate Injection	Current — Milla Pharmaceuticals
Icatibant Acetate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Bupivacaine Hydrochloride Injection	Current — Hospira, Inc., a Pfizer Company
Carboplatin Injection	Current — Avyxa Pharma, LLC
Bupivacaine Hydrochloride Injection	Current — Hospira, Inc., a Pfizer Company
Activated Charcoal Oral Suspension	To Be Discontinued — Padagis US LLC
Gadoterate Meglumine Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Iron Sucrose Injection	To Be Discontinued — Mylan Institutional, a Viatris Company
Cisatracurium Besylate Injection	To Be Discontinued — Hospira, Inc., a Pfizer Company
Dehydrated Alcohol Injection, Solution	To Be Discontinued — Accord Healthcare Inc.
Icatibant Acetate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Quinapril/Hydrochlorothiazide Tablet	Current — Pfizer Inc.
Cromolyn Sodium Concentrate	Current — Ailex Pharmaceuticals
Sulconazole Nitrate Solution	To Be Discontinued — Journey Medical Corporation
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Tiagabine Hydrochloride Tablet	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Idelalisib Tablet	To Be Discontinued — Gilead Sciences, Inc.
Dextrose Monohydrate 5% Injection	Current — Baxter Healthcare
Dextrose Monohydrate 5% Injection	Current — Baxter Healthcare
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Ketorolac Tromethamine Tablet	To Be Discontinued — Mylan Pharmaceuticals Inc., a Viatris Company
Tiagabine Hydrochloride Tablet	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Azithromycin Tablet	To Be Discontinued — Pfizer Inc.
Etravirine Tablet	To Be Discontinued — Janssen Research and Development
Aprepitant Oral Powder for Suspension	To Be Discontinued — Merck Sharp & Dohme LLC
Palbociclib Capsule	To Be Discontinued — Pfizer Inc.
Azithromycin Tablet	To Be Discontinued — Pfizer Inc.
Riluzole Oral Suspension	Current — EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)
Midazolam Hydrochloride Injection	Current — Gland Pharma Limited
Nitroglycerin Ointment	To Be Discontinued — AbbVie Inc.
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Idelalisib Tablet	To Be Discontinued — Gilead Sciences, Inc.
Fosaprepitant Dimeglumine Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Tiagabine Hydrochloride Tablet	To Be Discontinued — Teva Pharmaceuticals USA, Inc.
Midazolam Hydrochloride Injection	Current — Gland Pharma Limited
Lamotrigine Tablet, Extended Release	To Be Discontinued — Par Health, Inc.
Nitrofurantoin Oral Suspension	To Be Discontinued — Amneal Pharmaceuticals
Etravirine Tablet	To Be Discontinued — Janssen Research and Development